• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

timothy.spelman@unimelb.edu.au

Credentials


Position
Research Statistician
Department of Surgery
ORCID

0000-0001-9204-3216

Dr Timothy Spelman

Research Statistician
Department of Surgery

610 Scholarly works
8 Projects

HIGHLIGHTS

  • 2026

    Journal article

    C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections offices
    DOI: 10.1186/s40352-026-00411-6
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Australian SPine Registry (ASPIRE) - Collecting, Analysing, Evaluating and Protecting Australians After Spine Surgery
  • 2023

    Research contracts (non-grants)

    Effect of Subcutaneous Tirzepatide Once-Weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial
  • 2021

    Journal article

    Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
    DOI: 10.1212/WNL.0000000000012753
  • 2016

    Research Grant

    Centre for Research Excellence in Total Joint Replacement Optimising Outcomes, Equity, Cost Effectiveness and Patient Selection (Opus)
  • 2015

    Journal article

    Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
    DOI: 10.1002/ana.24339
  • 2013

    Journal article

    Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
    DOI: 10.1093/brain/awt281
Timothy Spelman

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Partially Ablative Body Radiation Therapy Versus Standard Palliative Radiation Therapy for Locally Advanced Bulky Unresectable Sarcomas
    DOI: 10.1016/j.adro.2026.102070
  • 2026

    Journal article

    Economic Evaluation of the Addition of Vancomycin to Cefazolin Prophylaxis in Patients Undergoing Arthroplasty
    DOI: 10.1007/s40273-026-01609-0
  • 2026

    Journal article

    Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years
    DOI: 10.1136/jnnp-2025-337367
  • 2026

    Journal article

    Increased Mortality in Chronic Hypoparathyroidism: A Nationwide Cohort Study in Sweden.
    DOI: 10.1530/EC-25-0450
  • 2026

    Journal article

    Corrigendum to “Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study” [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885] (Multiple Sclerosis and Related Disorders (2026) 106, (S2211034825006236), (10.1016/j.msard.2025.106885))
    DOI: 10.1016/j.msard.2026.107131
  • 2026

    Journal article

    Development of a Digital Phenotype for Immune-Related Colitis
    DOI: 10.1200/CCI-25-00366
  • 2026

    Journal article

    A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria
    DOI: 10.1016/j.immuni.2026.02.003
  • 2026

    Journal article

    QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus Outcomes
    DOI: 10.1111/tid.70152

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224